CLINICAL_TRIALS
trial_result
· 2021-06-15
Clinical Trial Update: Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation [Phase 2]
Summary
Phase 2 trial assessing the efficacy and safety of oral OPS-2071 in Crohn's disease with active inflammation; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-06-15